Literature DB >> 7637015

Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.

M Katzman1, M Sudol.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) and visna virus integrases were purified from a bacterial expression system and assayed on oligonucleotide substrates derived from each terminus of human immunodeficiency virus type 1 and visna virus linear DNA. Three differences between the proteins were identified, including levels of specific 3'-end processing, patterns of strand transfer, and target site preferences. To map domains of integrase (IN) responsible for viral DNA specificity and target site selection, we constructed and purified chimeric proteins in which the N-terminal, central, and C-terminal regions of these lentiviral integrases were exchanged. All six chimeric proteins were active for disintegration, demonstrating that the active site in the central region of each chimera maintained a functional conformation. Analysis of endonucleolytic processing activity indicated that the N terminus of IN does not contribute to viral DNA specificity; this function must reside in the central region or C terminus of IN. In the viral DNA integration assay, chimeric proteins gave novel patterns of strand transfer products which did not match that of either wild-type IN. Thus, target site selection with a viral DNA terminus as nucleophile could not be mapped to regions of IN defined by these boundaries and may involve interactions between regions. In contrast, when target site preferences were monitored with a new assay in which glycerol stimulates IN-mediated cleavage of nonviral DNA, chimeras clearly segregated between the two wild-type patterns. Target site selection for this nonspecific alcoholysis activity mapped to the central region of IN. This report represents the first detailed description of functional chimeras between any two retroviral integrases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637015      PMCID: PMC189427     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection.

Authors:  P M Pryciak; H E Varmus
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

2.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

4.  Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.

Authors:  C J Burke; G Sanyal; M W Bruner; J A Ryan; R L LaFemina; H L Robbins; A S Zeft; C R Middaugh; M G Cordingley
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

5.  Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro.

Authors:  M Drelich; R Wilhelm; J Mous
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

6.  Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis.

Authors:  A M Woerner; C J Marcus-Sekura
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

7.  Characterization of recombinant murine leukemia virus integrase.

Authors:  I Dotan; B P Scottoline; T S Heuer; P O Brown
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein.

Authors:  A M Woerner; M Klutch; J G Levin; C J Marcus-Sekura
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

9.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions.

Authors:  P A Sherman; M L Dickson; J A Fyfe
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more
  28 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.

Authors:  M H Nymark-McMahon; S B Sandmeyer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Authors:  Malgorzata Sudol; Jennifer L Fritz; Melissa Tran; Gavin P Robertson; Julie B Ealy; Michael Katzman
Journal:  Antivir Chem Chemother       Date:  2011-10-07

6.  Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.

Authors:  J L Gerton; S Ohgi; M Olsen; J DeRisi; P O Brown
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

8.  Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.

Authors:  Sanggu Kim; Alice Rusmevichientong; Beihua Dong; Roland Remenyi; Robert H Silverman; Samson A Chow
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro.

Authors:  Konstantin D Taganov; Isabel Cuesta; René Daniel; Lisa Ann Cirillo; Richard A Katz; Kenneth S Zaret; Anna Marie Skalka
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.